The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flynn, J. L.
Right arrow Articles by Bloom, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flynn, J. L.
Right arrow Articles by Bloom, B. R.

The Journal of Immunology, Vol 155, Issue 5 2515-2524, Copyright © 1995 by American Association of Immunologists


ARTICLES

IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection

JL Flynn, MM Goldstein, KJ Triebold, J Sypek, S Wolf and BR Bloom
Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

IL-12, a cytokine produced by macrophages and B cells, has recently been found to exert pleiotropic effects on the immune system. When BALB/c mice, a strain highly susceptible to virulent Mycobacterium tuberculosis infection, were given IL-12 at the initiation of infection with M. tuberculosis, their mean survival time doubled from 58 to 112 days. IL-12-treated mice had diminished bacterial burdens, whereas treatment with exogenous IFN-gamma had no effect on survival or bacterial burden. IL-12 treatment also delayed lung pathology in BALB/c mice. In contrast with the findings in the BALB/c model, IL-12 did not increase survival of M. tuberculosis-infected gko mice, transgenic mice in which the IFN-gamma gene has been disrupted, indicating that IL-12 does not induce protection against tuberculosis in mice in the absence of IFN-gamma.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
D. Sinsimer, G. Huet, C. Manca, L. Tsenova, M.-S. Koo, N. Kurepina, B. Kana, B. Mathema, S. A. E. Marras, B. N. Kreiswirth, et al.
The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence
Infect. Immun., July 1, 2008; 76(7): 3027 - 3036.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Ruan, L. McKinley, M. Zheng, X. Rudner, A. D'Souza, J. K. Kolls, and J. E. Shellito
Interleukin-12 and Host Defense against Murine Pneumocystis Pneumonia
Infect. Immun., May 1, 2008; 76(5): 2130 - 2137.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Young Goo, Y. S. Han, W. H. Kim, K.-H. Lee, and S.-J. Park
Vibrio vulnificus IlpA-induced Cytokine Production Is Mediated by Toll-like Receptor 2
J. Biol. Chem., September 21, 2007; 282(38): 27647 - 27658.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ordway, M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, C. Shanley, R. J. Basaraba, and I. M. Orme
The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation
J. Immunol., July 1, 2007; 179(1): 522 - 531.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. L. Taylor, J. M. Hattle, S. A. Dreitz, J. M. Troudt, L. S. Izzo, R. J. Basaraba, I. M. Orme, L. M. Matrisian, and A. A. Izzo
Role for Matrix Metalloproteinase 9 in Granuloma Formation during Pulmonary Mycobacterium tuberculosis Infection
Infect. Immun., November 1, 2006; 74(11): 6135 - 6144.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. A. Khader, S. Partida-Sanchez, G. Bell, D. M. Jelley-Gibbs, S. Swain, J. E. Pearl, N. Ghilardi, F. J. deSauvage, F. E. Lund, and A. M. Cooper
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
J. Exp. Med., July 10, 2006; 203(7): 1805 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ordway, M. Harton, M. Henao-Tamayo, R. Montoya, I. M. Orme, and M. Gonzalez-Juarrero
Enhanced Macrophage Activity in Granulomatous Lesions of Immune Mice Challenged with Mycobacterium tuberculosis.
J. Immunol., April 15, 2006; 176(8): 4931 - 4939.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
J. Exp. Med., December 19, 2005; 202(12): 1715 - 1724.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Kipnis, S. Irwin, A. A. Izzo, R. J. Basaraba, and I. M. Orme
Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population
Infect. Immun., November 1, 2005; 73(11): 7759 - 7764.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. I. Happel, E. A. Lockhart, C. M. Mason, E. Porretta, E. Keoshkerian, A. R. Odden, S. Nelson, and A. J. Ramsay
Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs
Infect. Immun., September 1, 2005; 73(9): 5782 - 5788.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. S. Duckett, S. Olmos, D. M. Durrant, and D. W. Metzger
Intranasal Interleukin-12 Treatment for Protection against Respiratory Infection with the Francisella tularensis Live Vaccine Strain
Infect. Immun., April 1, 2005; 73(4): 2306 - 2311.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. G. Feng, D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher
Maintenance of Pulmonary Th1 Effector Function in Chronic Tuberculosis Requires Persistent IL-12 Production
J. Immunol., April 1, 2005; 174(7): 4185 - 4192.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. T. Giles and J. M. Bathon
Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases
J Intensive Care Med, November 1, 2004; 19(6): 320 - 334.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
M. G. Hartley, M. Green, G. Choules, D. Rogers, D. G. C. Rees, S. Newstead, A. Sjostedt, and R. W. Titball
Protection Afforded by Heat Shock Protein 60 from Francisella tularensis Is Due to Copurified Lipopolysaccharide
Infect. Immun., July 1, 2004; 72(7): 4109 - 4113.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Nolt and J. L. Flynn
Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis
Infect. Immun., May 1, 2004; 72(5): 2976 - 2988.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Ness, C. M. Hogaboam, R. M. Strieter, and S. L. Kunkel
Immunomodulatory Role of CXCR2 During Experimental Septic Peritonitis
J. Immunol., October 1, 2003; 171(7): 3775 - 3784.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Turner, M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper
In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice
J. Immunol., December 1, 2002; 169(11): 6343 - 6351.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y.-j. Li, M. Petrofsky, and L. E. Bermudez
Mycobacterium tuberculosis Uptake by Recipient Host Macrophages Is Influenced by Environmental Conditions in the Granuloma of the Infectious Individual and Is Associated with Impaired Production of Interleukin-12 and Tumor Necrosis Factor Alpha
Infect. Immun., November 1, 2002; 70(11): 6223 - 6230.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Chackerian, J. Alt, V. Perera, and S. M. Behar
Activation of NKT Cells Protects Mice from Tuberculosis
Infect. Immun., November 1, 2002; 70(11): 6302 - 6309.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kinjo, K. Kawakami, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Hoshino, M. Okamoto, Y. Kawase, K. Yokota, et al.
Contribution of IL-18 to Th1 Response and Host Defense Against Infection by Mycobacterium tuberculosis: A Comparative Study with IL-12p40
J. Immunol., July 1, 2002; 169(1): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Hickman, J. Chan, and P. Salgame
Mycobacterium tuberculosis Induces Differential Cytokine Production from Dendritic Cells and Macrophages with Divergent Effects on Naive T Cell Polarization
J. Immunol., May 1, 2002; 168(9): 4636 - 4642.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. Palendira, A. T. Kamath, C. G. Feng, E. Martin, P. J. Chaplin, J. A. Triccas, and W. J. Britton
Coexpression of Interleukin-12 Chains by a Self-Splicing Vector Increases the Protective Cellular Immune Response of DNA and Mycobacterium bovis BCG Vaccines against Mycobacterium tuberculosis
Infect. Immun., April 1, 2002; 70(4): 1949 - 1956.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Cooper, A. Kipnis, J. Turner, J. Magram, J. Ferrante, and I. M. Orme
Mice Lacking Bioactive IL-12 Can Generate Protective, Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present
J. Immunol., February 1, 2002; 168(3): 1322 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. J. Nau, J. F. L. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young
Human macrophage activation programs induced by bacterial pathogens
PNAS, January 17, 2002; (2002) 22649799.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Wagner, F. J. Sangari, S. Kim, M. Petrofsky, and L. E. Bermudez
Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo
J. Leukoc. Biol., January 1, 2002; 71(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
C. J. Godshall, A. B. Lentsch, J. C. Peyton, M. J. Scott, and W. G. Cheadle
STAT4 Is Required for Antibacterial Defense but Enhances Mortality during Polymicrobial Sepsis
Clin. Vaccine Immunol., November 1, 2001; 8(6): 1044 - 1048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kim, K. Uyemura, M. K. Van Dyke, A. J. Legaspi, T. H. Rea, K. Shuai, and R. L. Modlin
A Role for IL-12 Receptor Expression and Signal Transduction in Host Defense in Leprosy
J. Immunol., July 15, 2001; 167(2): 779 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Nigou, C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo
Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor
J. Immunol., June 15, 2001; 166(12): 7477 - 7485.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Hogan, K. Macvilay, B. Barger, D. Co, I. Malkovska, G. Fennelly, and M. Sandor
Mycobacterium bovis Strain Bacillus Calmette-Guerin-Induced Liver Granulomas Contain a Diverse TCR Repertoire, but a Monoclonal T Cell Population Is Sufficient for Protective Granuloma Formation
J. Immunol., May 15, 2001; 166(10): 6367 - 6375.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Li, L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, and S. Qian
IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance
J. Immunol., May 1, 2001; 166(9): 5619 - 5628.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Demangel, U. Palendira, C. G. Feng, A. W. Heath, A. G. D. Bean, and W. J. Britton
Stimulation of Dendritic Cells via CD40 Enhances Immune Responses to Mycobacterium tuberculosis Infection
Infect. Immun., April 1, 2001; 69(4): 2456 - 2461.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. A. Chackerian, T. V. Perera, and S. M. Behar
Gamma Interferon-Producing CD4+ T Lymphocytes in the Lung Correlate with Resistance to Infection with Mycobacterium tuberculosis
Infect. Immun., April 1, 2001; 69(4): 2666 - 2674.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. A. Post, C. Manca, O. Neyrolles, B. Ryffel, D. B. Young, and G. Kaplan
Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Mycobacterium smegmatis-Induced Cytokine Production by Human Macrophages In Vitro
Infect. Immun., March 1, 2001; 69(3): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Wigginton and D. Kirschner
A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis
J. Immunol., February 1, 2001; 166(3): 1951 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. K. Brieland, C. Jackson, S. Hurst, D. Loebenberg, T. Muchamuel, R. Debets, R. Kastelein, T. Churakova, J. Abrams, R. Hare, et al.
Immunomodulatory Role of Endogenous Interleukin-18 in Gamma Interferon-Mediated Resolution of Replicative Legionella pneumophila Lung Infection
Infect. Immun., December 1, 2000; 68(12): 6567 - 6573.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Wakeham, J. Wang, and Z. Xing
Genetically Determined Disparate Innate and Adaptive Cell-Mediated Immune Responses to Pulmonary Mycobacterium bovis BCG Infection in C57BL/6 and BALB/c Mice
Infect. Immun., December 1, 2000; 68(12): 6946 - 6953.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. V. Lyadova, E. B. Eruslanov, S. V. Khaidukov, V. V. Yeremeev, K. B. Majorov, A. V. Pichugin, B. V. Nikonenko, T. K. Kondratieva, and A. S. Apt
Comparative Analysis of T Lymphocytes Recovered from the Lungs of Mice Genetically Susceptible, Resistant, and Hyperresistant to Mycobacterium tuberculosis-Triggered Disease
J. Immunol., November 15, 2000; 165(10): 5921 - 5931.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Elhofy, I. Marriott, and K. L. Bost
Salmonella Infection Does Not Increase Expression and Activity of the High Affinity IL-12 Receptor
J. Immunol., September 15, 2000; 165(6): 3324 - 3332.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
X. Ma and L. J. Montaner
Proinflammatory response and IL-12 expression in HIV-1 infection
J. Leukoc. Biol., September 1, 2000; 68(3): 383 - 390.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
T. YAMAGUCHI, Y. HIRAKATA, K. IZUMIKAWA, Y. MIYAZAKI, S. MAESAKI, K. TOMONO, Y. YAMADA, S. KOHNO, and S. KAMIHIRA
Prolonged survival of mice with Pseudomonas aeruginosa-induced sepsis by rIL-12 modulation of IL-10 and interferon-{gamma}
J. Med. Microbiol., August 1, 2000; 49(8): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. S. Yamauchi, J. R. Bleharski, K. Uyemura, J. Kim, P. A. Sieling, A. Miller, H. Brightbill, K. Schlienger, T. H. Rea, and R. L. Modlin
A Role for CD40-CD40 Ligand Interactions in the Generation of Type 1 Cytokine Responses in Human Leprosy
J. Immunol., August 1, 2000; 165(3): 1506 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. L. Freidag, G. B. Melton, F. Collins, D. M. Klinman, A. Cheever, L. Stobie, W. Suen, and R. A. Seder
CpG Oligodeoxynucleotides and Interleukin-12 Improve the Efficacy of Mycobacterium bovis BCG Vaccination in Mice Challenged with M. tuberculosis
Infect. Immun., May 1, 2000; 68(5): 2948 - 2953.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. J. Maeurer, P. Trinder, G. Hommel, W. Walter, K. Freitag, D. Atkins, and S. Storkel
Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice
Infect. Immun., May 1, 2000; 68(5): 2962 - 2970.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Elhofy and K. L. Bost
Limited Interleukin-18 Response in Salmonella-Infected Murine Macrophages and in Salmonella-Infected Mice
Infect. Immun., October 1, 1999; 67(10): 5021 - 5026.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. D. Brightbill, D. H. Libraty, S. R. Krutzik, R. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al.
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Science, July 30, 1999; 285(5428): 732 - 736.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. S. Cowdery, N. J. Boerth, L. A. Norian, P. S. Myung, and G. A. Koretzky
Differential Regulation of the IL-12 p40 Promoter and of p40 Secretion by CpG DNA and Lipopolysaccharide
J. Immunol., June 1, 1999; 162(11): 6770 - 6775.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Steinhauser, C. M. Hogaboam, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel
Multiple Roles for IL-12 in a Model of Acute Septic Peritonitis
J. Immunol., May 1, 1999; 162(9): 5437 - 5443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Huang, M.-D. Wang, S. Lenz, D. Gao, and B. Kaltenboeck
IL-12 Administered During Chlamydia psittaci Lung Infection in Mice Confers Immediate and Long-Term Protection and Reduces Macrophage Inflammatory Protein-2 Level and Neutrophil Infiltration in Lung Tissue
J. Immunol., February 15, 1999; 162(4): 2217 - 2226.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Teitelbaum, A. Glatman-Freedman, B. Chen, J. B. Robbins, E. Unanue, A. Casadevall, and B. R. Bloom
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
PNAS, December 22, 1998; 95(26): 15688 - 15693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Silva, T. F. Pais, and R. Appelberg
Evaluation of IL-12 in Immunotherapy and Vaccine Design in Experimental Mycobacterium avium Infections
J. Immunol., November 15, 1998; 161(10): 5578 - 5585.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hensler, C.-D. Heidecke, H. Hecker, K. Heeg, H. Bartels, N. Zantl, H. Wagner, J.-R. Siewert, and B. Holzmann
Increased Susceptibility to Postoperative Sepsis in Patients with Impaired Monocyte IL-12 Production
J. Immunol., September 1, 1998; 161(5): 2655 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wakeham, J. Wang, J. Magram, K. Croitoru, R. Harkness, P. Dunn, A. Zganiacz, and Z. Xing
Lack of Both Types 1 and 2 Cytokines, Tissue Inflammatory Responses, and Immune Protection During Pulmonary Infection by Mycobacterium bovis Bacille Calmette-Guerin in IL-12-Deficient Mice
J. Immunol., June 15, 1998; 160(12): 6101 - 6111.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. L. Baldwin, C. D'Souza, A. D. Roberts, B. P. Kelly, A. A. Frank, M. A. Lui, J. B. Ulmer, K. Huygen, D. M. McMurray, and I. M. Orme
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis
Infect. Immun., June 1, 1998; 66(6): 2951 - 2959.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. Tateda, T. Matsumoto, Y. Ishii, N. Furuya, A. Ohno, S. Miyazaki, and K. Yamaguchi

Clin. Vaccine Immunol., May 1, 1998; 5(3): 401 - 403.
[Abstract]


Home page
J. Immunol.Home page
M. G. Bonecini-Almeida, S. Chitale, I. Boutsikakis, J. Geng, H. Doo, S. He, and J. L. Ho
Induction of In Vitro Human Macrophage Anti-Mycobacterium tuberculosis Activity: Requirement for IFN-{gamma} and Primed Lymphocytes
J. Immunol., May 1, 1998; 160(9): 4490 - 4499.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Campos-Neto, P. Ovendale, T. Bement, T. A. Koppi, W. C. Fanslow, M. A. Rossi, and M. R. Alderson
Cutting Edge: CD40 Ligand Is Not Essential for the Development of Cell-Mediated Immunity and Resistance to Mycobacterium tuberculosis
J. Immunol., March 1, 1998; 160(5): 2037 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. F. Silver, Q. Li, W. H. Boom, and J. J. Ellner
Lymphocyte-Dependent Inhibition of Growth of Virulent Mycobacterium tuberculosis H37Rv Within Human Monocytes: Requirement for CD4+ T Cells in Purified Protein Derivative-Positive, But Not in Purified Protein Derivative-Negative Subjects
J. Immunol., March 1, 1998; 160(5): 2408 - 2417.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Flynn, C. A. Scanga, K. E. Tanaka, and J. Chan2
Effects of Aminoguanidine on Latent Murine Tuberculosis
J. Immunol., February 15, 1998; 160(4): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Piccotti, K. Li, S. Y. Chan, J. Ferrante, J. Magram, E. J. Eichwald, and D. K. Bishop
Alloantigen-Reactive Th1 Development in IL-12-Deficient Mice
J. Immunol., February 1, 1998; 160(3): 1132 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. K. Brieland, D. G. Remick, M. L. LeGendre, N. C. Engleberg, and J. C. Fantone
In Vivo Regulation of Replicative Legionella pneumophila Lung Infection by Endogenous Interleukin-12
Infect. Immun., January 1, 1998; 66(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. M. Cooper, J. Magram, J. Ferrante, and I. M. Orme
Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis
J. Exp. Med., July 7, 1997; 186(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. P. Taylor and H. W. Murray
Intracellular Antimicrobial Activity in the Absence of Interferon-gamma : Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-gamma Gene-disrupted M